INTRODUCTION {#s1}
============

Vertebrate embryos develop in a highly organized fashion, progressively laying down axial tissues as they elongate along the anteroposterior embryonic axis ([@BIO047290C1]; [@BIO047290C4]; [@BIO047290C46]; [@BIO047290C47]). Serial transplantation and other lineage tracing studies in mouse and chick have shown that a self-maintaining region in the tailbud called the chordoneural hinge (CNH) includes multipotent stem-cell-like progenitors for axial structures ([@BIO047290C1]; [@BIO047290C4]; [@BIO047290C46]; [@BIO047290C47]). These include bipotent neuromesodermal progenitors (NMPs) that can generate both neural and mesodermal cells ([@BIO047290C2]; [@BIO047290C3]; [@BIO047290C22]; [@BIO047290C38]; [@BIO047290C42]; [@BIO047290C44]).

Adjacent to the CNH is the tailbud mesoderm (TBM) that contains the unsegmented precursors of the paraxial mesoderm; the presomitic mesoderm (PSM; [Fig. 1](#BIO047290F1){ref-type="fig"}A). During elongation, the PSM is displaced posteriorly while its anterior buds off a series of somites, epithelial balls that develop into segmental mesodermal structures such as the axial skeleton and musculature (reviewed in [@BIO047290C29]). Fig. 1.**CNH transcriptome is distinct from PSM.** (A) Dissection of PSM, CNH and TBM of mouse at E10.5; (a) dorsal view of E10.5 tail, blue dashed rectangle represents dissected PSM and, (b) lateral view of a after removing PSM from last somite till end of tail, green dashed rectangle represents dissected CNH, black dashed rectangle represents dissected TBM; (c) schematic of tail regions with anterior to the left. Text colours correspond to those of different posterior axial regions colours (NT, neural tube; NC, notochord; PSM, presomitic mesoderm; TBM, tail bud mesoderm). Two biological and one technical replicates were performed for all three tissues (PSM, TBM and CNH). (B) A dendrogram illustrating the replicates\' reproducibility, derived by hierarchical clustering of their transcriptomes (see Materials and Methods). (C) Heatmap showing differentially expressed genes (fold change \>2 and \<−2, and *P*-value \<0.05) in the CNH, TBM and PSM. (D) Pathway enrichment analysis (see Materials and Methods). y-axis shows -log~10~(*P*-value) with enriched GO terms along the x-axis.

Several studies have illuminated how axial progenitors are maintained during anteroposterior elongation. Briefly, a positive feedback loop between Brachyury/T and Wnt3a maintains axial progenitors in the tail bud ([@BIO047290C20]; [@BIO047290C47]). In parallel, Fgf signalling protects axial progenitors from differentiation induced by retinoic acid (RA) that is secreted by differentiating and young somites and diffuses into the PSM ([@BIO047290C8]; [@BIO047290C26]; [@BIO047290C32]).

However, Fgf8, Wnt3 and T are all expressed in much larger domains than the CNH and so do not specifically distinguish axial progenitors from more specialised cells such as the TBM. Transcriptome analysis of dissected axial progenitor tissue during the period of axial elongation and of *in vitro*-derived NMPs has identified genes that are differentially expressed between progenitors and presomitic mesoderm cells ([@BIO047290C12]; [@BIO047290C27]; [@BIO047290C48]). However, the functional significance of many of these genes has yet to be defined.

In this paper, we explore the transcriptional profiles of the CNH, TBM and PSM of E10.5 mouse embryos. We find that the CNH transcriptome is very similar to that of the TBM, and significantly different from that of the PSM. Several genes are expressed in both the CNH and TBM but not in the PSM, although none exclusively mark the CNH. Amongst the CNH-enriched transcripts is *Greb1*, which encodes a transcriptional co-activator for androgen/oestrogen hormone signalling. We show that *Greb1* is expressed in the tailbud in mouse, chick and zebrafish embryos, and is required for axial progenitor maintenance and somite compartmentalisation in zebrafish. Our results indicate that Greb1 plays an evolutionarily-conserved role during vertebrate axial extension and segmentation.

RESULTS AND DISCUSSION {#s2}
======================

CNH transcriptome is distinct from PSM but not TBM {#s2a}
--------------------------------------------------

To identify potential markers for the CNH, we used microarray analysis on dissected tissue regions to identify genes whose expression in the E10.5 mouse CNH is elevated relative to that in the PSM and TBM ([Fig. 1](#BIO047290F1){ref-type="fig"}A). Hierarchical clustering of the replicate transcriptome patterns confirmed that the transcriptional profiles of the CNH, PSM and TBM are distinct ([Fig. 1](#BIO047290F1){ref-type="fig"}B; see Materials and Methods). Differential gene expression analyses identified 150 upregulated and 98 downregulated genes comparing the CNH to the PSM. The most significantly changed genes are listed briefly in [Table 1](#BIO047290TB1){ref-type="table"}, and the complete list can be found in [Table S1](Table S1). Only 12 upregulated and two downregulated transcripts distinguished the CNH and TBM, which is consistent with the latter population being directly derived from the former ([Table 1](#BIO047290TB1){ref-type="table"}; [Table S1](Table S1)).Table 1.**List of differentially expressed genes in the CNH (FDR\<0.01; fold change \>2 or \<−2).**

To confirm that many genes identified by microarray analysis are selectively expressed in progenitor regions of the extending embryo, we searched the Mouse Genome Informatics (MGI) database ([@BIO047290C11]) for the expression patterns of 53 genes whose expression were upregulated ≥2-fold in the CNH ([Fig. 1](#BIO047290F1){ref-type="fig"}C). A majority of these genes (29/53) are annotated as being expressed in tissues related to axial elongation, i.e. in one or more of the primitive streak, node, tailbud and future spinal cord ([Table 2](#BIO047290TB2){ref-type="table"}; [Table S2](Table S2)). By contrast, most downregulated genes (23/27 reduced ≥2-fold) are expressed in more specialised progeny cells, i.e. somites, unsegmented mesoderm or neural tube ([Table 2](#BIO047290TB2){ref-type="table"}; [Table S2](Table S2)).Table 2.**Annotated gene expression patterns (E7.5--13.5 mouse embryos) for genes that are differentially expressed in the CNH**

Greb1 expression coincides with axial elongation in vertebrate embryos {#s2b}
----------------------------------------------------------------------

We also compared our list of CNH-enriched genes with those previously identified in previous studies of the CNH or NMPs ([Table S3](Table S3); [@BIO047290C12]; [@BIO047290C27]; [@BIO047290C48]). Expression of seven of the ten most-enriched genes (*Fgf8*, *Cdx2*, *T*, *Wnt3a*, *Sp5*, *Evx1* and *Fgf17*) was previously reported in the CNH and TBM, and to be functionally important for axial development ([@BIO047290C3]; [@BIO047290C10]; [@BIO047290C21]; [@BIO047290C40]).

The expression and roles of the two most CNH-enriched genes from our study \[*Defcr-rs7*, *Defcr*-*rs6* (which encode small immune-defect peptides)\] during axial elongation and segmentation remains to be studied. *Greb1*, which encodes a co-activator of the oestrogen and androgen receptors that is active in human oestrogen-receptor-positive primary breast and prostate cancer cells ([@BIO047290C19]; [@BIO047290C23]), is another top CNH enriched gene. Indeed, androgen receptor nuclear signalling is the most CNH-enriched pathway revealed by pathway enrichment analysis of our differentially expressed genes ([Fig. 1](#BIO047290F1){ref-type="fig"}D; [Table S4](Table S4); see Materials and Methods). Other androgen-responsive genes also enriched in the CNH include *P21*, *cyclinD1* and *MMP2* ([Table S3](Table S3)). Indeed, the MMP2 matrix metalloproteinase is required for axial elongation -- morpholino knockdown of *MMP2* in zebrafish embryos -- results in severe axial truncations ([@BIO047290C50]). Further studies will be required to test if androgen signalling operates in axial patterning.

Expression of chick *Greb1* in the axial stem cell zone has been described previously ([@BIO047290C27]). We expanded this finding by examining *Greb1* expression during segmentation, using three different vertebrate systems. First, we visualised *Greb1* transcription in elongating mouse embryos using *in situ* hybridisation (E10.5--E13.5; see Materials and Methods). In early (E8.5) embryos, *Greb1* is expressed in a posterior domain that encompasses the caudal lateral epiblast, the region that includes the axial progenitors ([Fig. 2](#BIO047290F2){ref-type="fig"}A,A′). By E10.5, labelling is restricted to the CNH and dorsal TBM ([Fig. 2](#BIO047290F2){ref-type="fig"}B,B′). Expression in these regions is maintained during axial elongation, albeit more weakly by E12.5, and is lost at E13.5 when axial elongation ceases ([Fig. 2](#BIO047290F2){ref-type="fig"}C,D). Fig. 2.**The timing of axial *Greb1* expression is coincident** **with axial elongation in vertebrate embryos.** (A--D) Mouse embryos and their tail regions at different embryonic stages. (A,A′) Dorsal view of E8.5 embryo showing expression in the caudal lateral epiblast (CLE). PS: primitive streak. (B,B′) Lateral view of E10.5 embryo, showing the *Greb1-*expressing tail region. (C) Lateral view of E12.5 tail region, showing reduced *Greb1* expression. (D) Lateral view of E13.5 tail region, showing that expression is lost. (E--F) *Greb1* expression in chick embryos at different stages: (E,E′) dorsal views of HH13 embryo and its tail region; (F) lateral and (F′) ventral view of a tail region at HH17; (G) lateral view of HH26 embryo, showing that *Greb1* expression in the tailbud is almost gone. H--L are lateral views of zebrafish embryos of the indicated ages (hpf, hours post-fertilisation). Each pattern was analysed in two independent experiments using, for each stage, at least five mouse, or 10--15 chicken or zebrafish embryos. Tailbud regions are arrowed. Boxes in lower magnification images show the tail regions with magnified views in the adjacent panel.

The above results show that, although not restricted to the CNH, axial *Greb1* transcription in early mouse embryos coincides in time and place with the processes of axial extension and segmentation. To test if this correlation is evolutionarily conserved, we examined *Greb1* expression in chick and zebrafish embryos. In both animals, *Greb1* expression in the tailbud starts during elongation, and terminates when elongation and segmentation is complete. *Greb1* is expressed in the HH13 chick caudal neural plate, whose cells contribute to the neural tube, somites and notochord, node and primitive streak ([Fig. 2](#BIO047290F2){ref-type="fig"}E,E′). Its axial transcription then becomes confined to the region of the tailbud which includes the chick CNH and TBM (HH17; [Fig. 2](#BIO047290F2){ref-type="fig"}F; [@BIO047290C22]), and has almost completely decayed when elongation is complete (HH26; [Fig. 2](#BIO047290F2){ref-type="fig"}G).

In zebrafish embryos, *Greb1* transcription becomes confined to the region of the tailbud that contains axial progenitors ([Fig. 2](#BIO047290F2){ref-type="fig"}H--L). It persists during segmentation (11--16 hpf; [Fig. 2](#BIO047290F2){ref-type="fig"}I--K), and disappears when axial elongation comes to an end (24 hpf; [Fig. 2](#BIO047290F2){ref-type="fig"}L). This conserved spatial and temporal time course in early vertebrate embryos strengthens the link between *Greb1* expression and axial extension.

Knockdown of *GREB1* disrupts axial elongation {#s2c}
----------------------------------------------

To test if *Greb1* is functionally required during elongation and segmentation, we knocked down its expression by injecting antisense morpholinos into 1--2-cell zebrafish embryos (see Materials and Methods). We used two *Greb1* splicing-blocking morpholinos (M1 and M2) that target the exon2-intron2 and exon16-intron16 boundaries, respectively ([Fig. S1](Fig. S1)). These oligos should interfere with mRNA splicing to cause skipping of the adjacent exon and a shifted translational reading frame. The ensuing premature translational termination would completely truncate Greb1 protein (M1) or encode one that is only 40% full-length (M2). As a control, we also injected a mismatched morpholino (MM) based on M2 but with five bases mutated to prevent binding to the primary *Greb1* transcript.

We verified the splice-blocking activities of both morpholinos via RT-PCR on RNA from injected embryos. *Greb1* splice variants corresponding to misprocessed transcripts were detected in M1- and M2-injected morphants but not MM morphant embryos ([Fig. S1](Fig. S1)). DNA sequencing of these variant products confirmed that they result from skipping of the appropriate exons: exon 2 for oligo M1, and exon16 for M2 ([Fig. S1](Fig. S1)).

We assayed the effects of *Greb1* knockdown 24 h after injection into embryos, when extension and segmentation is complete. M1 and M2 morphant embryos suffer three major axial defects: a curved trunk; a reduction in total body length (head-to-tail); misshaped somites and indistinct somite boundaries predominantly in more posterior axial regions ([Fig. 3](#BIO047290F3){ref-type="fig"}A--C). Injection of 4 ng/µl blocking oligonucleotide generates a high frequency of embryos showing all three defects (50/107 injected embryos for M1; 61/110 embryos for M2). No such abnormalities are seen in embryos injected with the control MM morpholino (0/15). Injecting 2 ng/µl of morpholino causes similar defects, albeit at lower frequencies (M1: 11/46; M2: 15/36; MM: 0/8). Fig. 3.***Greb1* is required for** **axial elongation.** (A--C,A′--C′) Lateral views of zebrafish embryos at 24 hpf, showing: (A) wild-type chevrons of *xirp2a* expression and the tail region (bracketed); (B,C) posterior loss in M1 and M2 morphants. The tail regions that are truncated and contain disrupted somites are bracketed. (D--F,D′--F′): expression of *myoD* in control (MM, M1 and M2 morphants). (G,L) *papc*, (H,M) *mespa*, (I,N) *mespb*, (J,O) *her1*, (K,P) *her7* (Q,R) and (Q′,R′) *Ntl* expression in the tail region of 15 hpf control and morphant embryos*.* (S) A tentative model for gene interactions between Greb1 and patterning genes. Anterior expression of Her7 restricts *mespb* expression to the posterior somite compartment, which, in turn, restricts *myoD* and *papC* expression to the anterior compartment. Continuous arrows indicate interactions shown by others as likely to be direct. Dashed arrows could be direct or indirect.

These phenotypes are not due to unspecific toxicity from the injection. We co-injected each morpholino with one that knocks down *p53* expression, thereby preventing previously reported oligo-induced p53-dependent cell death (see Materials and Methods; [@BIO047290C34]). Each blocking morpholino still efficiently caused axial extension and segmentation phenotypes (M1: 20/30; M2: 25/37; control MM: 0/10). Together, our data suggest that normal axial elongation and segmentation are dependent on Greb1 activity.

Greb1 is needed to maintain *Ntl* expression in the tailbud {#s2d}
-----------------------------------------------------------

The axial truncations of *Greb1* morphants resembles the phenotype of embryos mutant for *No tail* (*Ntl*), the zebrafish homologue of *Brachyury/T*, which is expressed in the tailbud, posterior PSM and notochord of wild-type embryos ([@BIO047290C13]; [@BIO047290C37]). *Ntl* in the tailbud helps maintain axial progenitors by protecting them from premature differentiation induced by RA secreted by the anterior PSM and somites ([@BIO047290C8]; [@BIO047290C20]; [@BIO047290C26]; [@BIO047290C32]).

Tailbud *Ntl* expression in *Greb1* morphants is indeed much lower than in wild-type or control embryos (M2: 20/34; MM: 0/11; [Fig. 3](#BIO047290F3){ref-type="fig"}Q′,R,R′). Thus, *Greb1* is required for efficient *Ntl* expression, and reduced *Ntl* levels can explain the morphant embryos\' truncated axis.

*Greb1* depletion affects somite polarity via the segmentation clock {#s2e}
--------------------------------------------------------------------

During axial segmentation in zebrafish embryos, a linear array of chevron-shaped somites is progressively generated from the PSM between 10--24 hpf ([Fig. 3](#BIO047290F3){ref-type="fig"}A,A′). As mentioned above, *Greb1* morphants lack morphologically discrete somites ([Fig. 3](#BIO047290F3){ref-type="fig"}A--C).

To assess if this morphological phenotype is accompanied by altered gene expression at somite boundaries, we examined *xirp2a/cb1045*, which is expressed in the myoseptum between myotomes ([@BIO047290C6]; [@BIO047290C36]). Strong distinct posterior stripes of *Xirp2a* mRNA expression are frequently lost in *Greb1* morphant embryos (M1: 20/25; M2: 14/18; MM: 0/15; [Fig. 3](#BIO047290F3){ref-type="fig"}A--C), corresponding to the regions with abnormal somite appearance.

In wild-type embryos, boundaries arise between posterior and anterior compartments of adjacent somites, raising the possibility that *Greb1* is needed for somite compartmentalisation. To test this idea, we studied *myoD* transcripts, which are normally expressed in the posterior half of each somite ([@BIO047290C45]). By contrast, expression of *myoD* extends into the anterior compartment in *Greb1* morphants (M1: 7/15; M2: 13/18; MM: 0/18; [Fig. 3](#BIO047290F3){ref-type="fig"}D--F), suggesting that anterior morphant cells have adopted a posterior character. M1 and M2 morphants show similar effects on axial morphology and *Xirp2a* and *myoD* expression, we only analysed M2 morphants in subsequent experiments.

Analysing *papC*, which is expressed in the anterior compartments of newly formed somites ([@BIO047290C31]) provides additional support for the idea that *Greb1* contributes to the establishment of anterior compartmentalisation. In morphant embryos, *papC* levels are reduced and lack clear borders (M2:14/22; MM:0/22; [Fig. 3](#BIO047290F3){ref-type="fig"}G,L).

Expression of *myoD* is normally suppressed in anterior somite compartments by *mespb*, which together with *mespa*, is expressed there in newly-formed somites ([@BIO047290C35]). We examined expression of both *mesp* genes in the morphant embryos and found that, although *mespa* expression is not altered (M2: 0/24; MM:0/21; [Fig. 3](#BIO047290F3){ref-type="fig"}H,M), *mespb* expression is greatly lowered (M2: 6/10; MM: 0/21; [Fig. 3](#BIO047290F3){ref-type="fig"}I,N). This reduction explains why *myoD* is derepressed in *Greb1* morphants, and reinforces our view that *Greb1* is needed for somite compartmentalisation.

What might cause mis-specification of somite compartments? During vertebrate axial extension, the regular production of equal-sized segments results from the action of a molecular oscillator ('segmentation clock'), which drives cyclic transcription of many PSM genes with a period corresponding to that of somite formation ([@BIO047290C7]; [@BIO047290C24]; [@BIO047290C28]; [@BIO047290C29]). Together, axial extension and cyclic gene expression establish reiterated expression of genes that define somite compartmentalisation and, hence, somite boundaries.

We examined two such cycling genes, *her1* and *her7*, which encode transcriptional repressors whose periodic expression in the zebrafish PSM form and pattern the somites ([@BIO047290C25]; [@BIO047290C29]; [@BIO047290C41]). In particular, *her7* is a regulator of *mespb* expression in forming somites ([@BIO047290C5]; [@BIO047290C25]). Expression of *her1* is normal in the PSMs of *Greb1* morphant embryos (M2 0/16; MM 0/19; [Fig. 3](#BIO047290F3){ref-type="fig"}J,O), but that of *her7* is lost, in both the tailbud and PSM (M2 5/5; MM 0/5; [Fig. 3](#BIO047290F3){ref-type="fig"}K,P). The latter\'s loss explains the reduced *mespb* expression and abnormal somite compartmentalisation in *Greb1* morphant embryos.

Together, our experiments support the following model for the *Greb1* morphant phenotypes ([Fig. 3](#BIO047290F3){ref-type="fig"}S). Axial extension is truncated due to reduced expression of *Ntl* and, thereby, loss of axial progenitors ([Fig. 3](#BIO047290F3){ref-type="fig"}Q,Q′,R; [@BIO047290C20]), and the segmentation phenotype is caused by loss of *her7*. This model is consistent with the misregulation of *mespb* and loss of more posterior somite boundaries in both *her7* mutants and *Greb1* morphants ([Fig. 3](#BIO047290F3){ref-type="fig"}A--F, A′--F′; [@BIO047290C25]). Although we cannot completely exclude the possibility that the morphant morphological and molecular phenotypes are due to off-target knockdowns, this explanation seems unlikely. Each of the splice-blocking morpholinos was independently derived, and so they would not be expected affect similar sets of off-target transcripts. The combination of morphant phenotypes we observe has not previously been described, and we have also shown that they are not due to non-specific morphant toxicity. Future experiments using CRISPR/Cas9 gene-editing will clarify this point and allow further studies of *Greb1* action.

As Greb1, Ntl and Her7 are all transcription factors, some of the effects on gene transcription that we observe may be direct. Greb1 is required for clock output via *her7*, and may also act directly on *mespb*. However, the oscillator circuitry remains intact: morphants retain cyclic *her1* expression and low level, metameric *xirp2* expression ([Fig. 3](#BIO047290F3){ref-type="fig"}B,C,J,O). The latter idea would explain why *mespb* expression is abolished in the *Greb1* morphants ([Fig. 3](#BIO047290F3){ref-type="fig"}I,N). Although further experiments will be required to distinguish between direct and indirect actions of *Greb1* and its potential targets, the evolutionarily conserved pattern and time-course of *Greb1* expression that we have shown in mouse, chick and zebrafish ([Fig. 2](#BIO047290F2){ref-type="fig"}) suggest that *Greb1* is an important component in vertebrate axial patterning.

MATERIALS AND METHODS {#s3}
=====================

Maintenance and collection of embryos {#s3a}
-------------------------------------

E10.5 mouse embryos were collected from *CD1* and *C57Bl/6J* pregnant females (Charles River Laboratories International Inc., UK) in M2 media (Sigma-Aldrich, M7167). Fertilized chicken eggs from Henry Stewart & Co (Louth, UK) were incubated at 37°C, and embryos were staged according to Hamburger and Hamilton ([@BIO047290C14]). Adult wild-type zebrafish were maintained at 27°C on a regular 14 h light/10 h dark cycle, and embryos were collected and staged as described by Kimmel et al. ([@BIO047290C18]). *p53* heterozygous and homozygous mutant zebrafish embryos were obtained by crossing *p53* homozygous female to *p53* heterozygous males ([@BIO047290C34]). Animals used in this study were handled by professionals meeting all the requirements of the Animals (Scientific Procedures) Act 1986.

Transcription profiling {#s3b}
-----------------------

Mouse CNH, PSM and TBM explants per experiment were dissected as previously described ([Fig. 1](#BIO047290F1){ref-type="fig"}A; [@BIO047290C2]). Approximately 50 pieces of each region were pooled, and total RNA extracted using the RNeasy Mini Kit (Qiagen, cat. no. 74104). Before processing the RNA samples for microarray analysis, their quality was tested using the Bioanalyzer RNA 6000 Pico kit (Agilent, cat. no. 5067-1513). Samples with RNA integrity number (RIN) 8--10 were processed for transcriptional profiling at the Genome Centre (Blizard Institute, Barts and the London School of Medicine and Dentistry) using Illumina 'Ref6v2' beads arrays. Two biological and one technical replicate were carried out for each region -- CNH, TBM and PSM.

Microarray data analysis {#s3c}
------------------------

Analysis was performed using software packages developed for Bioconductor version 2.4.0 and R version 2.9.0. The Illumina dataset were processed using the probe intensity transformation (VST) and normalization (RSN) methods from the 'lumi' package ([@BIO047290C16]; [@BIO047290C43]). Hierarchical clustering was used to assay the reproducibility of the biological replicates. Differential gene expression was assessed between tissue-type replicate groups using an empirical Bayes\' *t*-test as implemented in the 'limma' package and taking account of replicate group and batch effects ([@BIO047290C17]). Three comparisons were performed: CNH versus PSM, CNH versus TBM, CNH versus Combined PSM and TBM. The resulting *P*-values were adjusted to control the false discovery rate (FDR) using the Benjamini and Hochberg method. Two lists of differentially expressed genes were produced using different thresholds: (1) all genes that exhibited FDR\<0.05 in all three comparisons, or a fold change \>1.5 in the same direction in all three contrasts were classified as differentially expressed. (2) 'Top50': genes were selected on the basis of FDR\<0.05 and an absolute fold change ≥1.5 from the CNH versus PSM comparison, ordered by fold change, and the top 50 most-changed genes were selected and clustered using hierarchical clustering algorithm. Genes from the two lists were combined and used to perform a pathway enrichment and network analysis with MetaCore software from Clarivate Analytics.

*In situ* hybridisation {#s3d}
-----------------------

We visualised spatiotemporal transcript expression in mouse, chick and zebrafish embryos by *in situ* hybridisation using digoxigenin-labelled antisense RNA probes ([@BIO047290C15]; [@BIO047290C30]; [@BIO047290C39]). In general, templates for making antisense RNA probes for *in situ* detection of *Greb1* transcripts were generated by RT-PCR of embryonic mRNA, cloning into *PCR2.1-TOPO-TA* vector (Invitrogen; [Table S5](Table S5)), linearization using *Spe1* or *Not1*, and transcription by T3 or T7 RNA polymerase. cDNA templates for generating other antisense-RNA probes were obtained from the Julian Lewis lab. Expression patterns were replicated and scored independently by at least two people.

Morpholino injection {#s3e}
--------------------

To knockdown zebrafish *Greb1* expression, we injected 2 nl of the following splicing-blocking morpholinos into 1--2-cell embryos at 2--8 ng/µl in 0.4 mM MgSO~4~, 0.6 mM CaCl~2~, 0.7 mM KCl, 58 mM NaCl, 5 mM HEPES pH 7.6; 0.05% Phenol Red: (M1) 5′-GGAAGACTGTAAAAGCTCACCCTCA-3′, (M2) 5′AATACTGAAATCACACCTCTCCTCC-3′ ([Fig. S1](Fig. S1); Gene Tools, Philomath, OR, USA). Control injections used a mutated M2 oligo (MM) with five nucleotide mismatches: 5′-AATAGTCAAATCAGACCTGTGCTCC-3′. To test for non-specific toxicity, 4 ng/µl of blocking or control morpholino was co-injected with 6 ng/µl *p53* antisense morpholino ([@BIO047290C34]). Efficacy and specificity were tested by sizing and sequencing RT-PCR products of total RNA from morpholino-injected embryos, SuperScript III One-Step RT-PCR mix (Invitrogen, \#12574035).
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